Blog archive

December's announcement of a Trade and Cooperation Agreement to steer the next steps in the future relationship between the UK and the EU was a welcome development.

Members of the European Union operate closely coordinated medicines approval systems, with innovative products coming within the remit of the EMEA for central approval.

We are delighted to learn of the The Royal Swedish Academy of Sciences to give the 2020 Nobel Prize in Chemistry to Emmanuelle Charpentier and Jennifer A. Doudna.

UK Government has issued new Brexit guidance for the life sciences sector. With the transition period coming to an end on 31 December, only three months remain before the Medicines and Healthcare products Regulatory Agency (MHRA) takes on...

In this article, we take a look at the guidance on licensing of medicines and related products, particularly marketing authorisations. This addresses the following topics...

In this article, we discuss the future for medical devices. Producers of medical devices will face major changes after the end of the transition period.

The COVID-19 pandemic is leading to an unusual level of disputes between commercial partners. It is also putting serious strain on court resources. Many contracting parties are turning to alternative methods of dispute resolution, with arbitration being a good choice for many.

Artificial Intelligence (AI) technology is advancing at a rapid pace, and playing an increasing role in drug discovery and healthcare. AI is being used to assist with early detection of diseases, including cancer, diagnosis, treatment, and in keeping us well. 

The Government has published further details about the new immigration system that is due to be implemented from 1 January 2021.

Many had thought that the combination of the UK’s withdrawal and the negative ruling of the German Constitutional Court in March had stopped this long-standing initiative in its tracks. Both the UK and Germany had central roles in the Unified Patent Court, and are essential to the ratification of the UPC Agreement.

At the end of last week, the European Court of Justice (CJEU) provided the 'Schrems II’ judgment. It is something which is already causing widespread shudders - not only for those involved in transferring personal data...

The UK Government's support scheme for innovative companies has been very successful, and is now being expanded to include...